APVO vs HIHO Comparison

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, CD3xCD123, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Highway Holdings Ltd manufactures and sells metal, plastic and electronic parts, components, subassemblies and finished products for OEMs and contract manufacturers. Its products are used in photocopiers, laser printers, print cartridges, electrical connectors, electrical circuits and other applications. The Company also offers tooling design and development, metal stamping, screen printing, plastic injection molding, pad printing and electronic assembly of printed circuit boards. It operates through metal stamping and mechanical OEM manufacturing operations and electronic OEM manufacturing operations, with metal stamping and mechanical OEM manufacturing operations generating maximum revenue. The Company generates maximum revenue from Europe.